Biological Mechanisms of Aging
The aging process refers to the progressive decline in physiological function that increases vulnerability to disease and death. At the cellular level, key drivers include genomic instability, telomere attrition, epigenetic alterations, and mitochondrial dysfunction. Research from the Hallmarks of Aging framework identifies these interconnected mechanisms as the core hallmarks of biological aging. In 2024, multi-omics studies continue to map how DNA damage accumulation and altered intercellular communication accelerate tissue deterioration.
Cellular Senescence and Inflammation
Cellular senescence is a state where cells permanently stop dividing but remain metabolically active, secreting pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP). This chronic, low-grade inflammation, often termed inflammaging, is a central feature of the aging process and is linked to conditions such as atherosclerosis, osteoarthritis, and neurodegeneration. The Hallmarks of Aging paper highlights how the accumulation of senescent cells drives tissue dysfunction and systemic decline.
Global Longevity Trends and Demographics
Global life expectancy at birth reached approximately 73.4 years in 2024, according to the latest World Health Organization data, though progress has slowed in many regions due to pandemics and conflict. The global population aged 65 and over now exceeds 770 million, representing roughly 10% of the world's total population. This demographic shift is reshaping labor markets, healthcare systems, and national fiscal policies, making the economic dimension of the aging process a central topic in public finance and corporate strategy.
Centenarian Growth and Super-Aging Societies
The number of centenarians worldwide has grown rapidly, with Japan reporting over 90,000 centenarians in its latest annual survey, a trend mirrored in the United States and other developed economies. Countries such as Japan, Italy, and South Korea are classified as super-aging societies, where more than 20% of the population is aged 65 or older. These statistics underscore the urgency of understanding the aging process not just as a biological phenomenon but as a structural economic and social challenge.
Financial and Corporate Implications of Longevity Risk
Longevity risk is the financial risk arising from individuals living longer than expected, which threatens the solvency of pension funds, insurance companies, and government entitlement programs. In 2024, major institutional investors and reinsurers are increasingly using advanced longevity models to price annuity products and adjust reserve calculations. The SEC filings of large financial institutions now routinely disclose longevity risk as a material factor affecting their balance sheets, reflecting the growing recognition of the aging process as a systemic financial variable.
Corporate Responses and Longevity Economy
Corporations are responding to the aging process by launching products and services targeting older consumers, from age-tech health monitoring devices to financial planning platforms for retirement. Companies like